Human thrombopoietin knockin mice efficiently support human hematopoiesis in vivo

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 6, 2011, Pages 2378-2383

  Rongvaux, Anthony ^a   Willinger, Tim ^a   Takizawa, Hitoshi ^a,b,c   Rathinam, Chozhavendan ^a   Auerbach, Wojtek ^d   Murphy, Andrew J ^d   Valenzuela, David M ^d   Yancopoulos, George D ^d   Eynon, Elizabeth E ^a   Stevens, Sean ^a,d,e   Manz, Markus G ^a,b,c   Flavell, Richard A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

^d REGENERON PHARMACEUTICALS INC   (United States)

^e AnaptysBio Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; THROMBOPOIETIN;

ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; CELL DIFFERENTIATION; HEMATOPOIESIS; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE;

ANIMALS; GENE KNOCK-IN TECHNIQUES; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MICE; MICE, TRANSGENIC; THROMBOPOIETIN; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HETEROLOGOUS;

MUS;

EID: 79952294749     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1019524108     Document Type: Article

References (44)

1. Kondo M, et al. (2003) Biology of hematopoietic stem cells and progenitors: Implications for clinical application. Annu Rev Immunol 21:759-806. (Pubitemid 37174547)
2. Chao MP, Seita J, Weissman IL (2008) Establishment of a normal hematopoietic and leukemia stem cell hierarchy. Cold Spring Harb Symp Quant Biol 73:439-449.
3. McCune JM, et al. (1988) The SCID-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function. Science 241:1632-1639.
4. Namikawa R, Kaneshima H, Lieberman M, Weissman IL, McCune JM (1988) Infection of the SCID-hu mouse by HIV-1. Science 242:1684-1686. (Pubitemid 19022172)
5. Baum CM, Weissman IL, Tsukamoto AS, Buckle AM, Peault B (1992) Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA 89:2804-2808.
6. Dick JE, Lapidot T (2005) Biology of normal and acute myeloid leukemia stem cells. Int J Hematol 82:389-396. (Pubitemid 46638686)
7. Shultz LD, Ishikawa F, Greiner DL (2007) Humanized mice in translational biomedical research. Nat Rev Immunol 7:118-130. (Pubitemid 46174859)
8. Legrand N, Weijer K, Spits H (2006) Experimental models to study development and function of the human immune system in vivo. J Immunol 176:2053-2058. (Pubitemid 43201649)
9. Ito M, et al. (2002) NOD/SCID/gamma(c)(null) mouse: An excellent recipient mouse model for engraftment of human cells. Blood 100:3175-3182. (Pubitemid 35217065)
10. Traggiai E, et al. (2004) Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 304:104-107. (Pubitemid 38451466)
11. Ishikawa F, et al. (2005) Development of functional human blood and immune systems in NOD/SCID/IL2 receptor gamma chain(null) mice. Blood 106:1565-1573. (Pubitemid 41208567)
12. Gimeno R, et al. (2004) Monitoring the effect of gene silencing by RNA interference in human CD34+ cells injected into newborn RAG2-/- gammac-/- mice: Functional inactivation of p53 in developing T cells. Blood 104:3886-3893. (Pubitemid 39620134)
13. Manz MG (2007)Human-hemato-lymphoid-system mice: Opportunities and challenges. Immunity 26:537-541.
14. Allsopp RC, Cheshier S, Weissman IL (2001) Telomere shortening accompanies increased cell cycle activity during serial transplantation of hematopoietic stem cells. J Exp Med 193:917-924. (Pubitemid 32525864)
15. Legrand N, et al. (2009) Humanized mice for modeling human infectious disease: Challenges, progress, and outlook. Cell Host Microbe 6:5-9.
16. Wendling F, et al. (1994) cMpl ligand is a humoral regulator of megakaryocytopoiesis. Nature 369:571-574.
17. Kaushansky K, et al. (1994) Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 369:568-571. (Pubitemid 24192526)
18. Lok S, et al. (1994) Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 369:565-568. (Pubitemid 24192525)
19. de Sauvage FJ, et al. (1994) Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 369:533-538.
20. Bartley TD, et al. (1994) Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 77:1117-1124.
21. Kaushansky K (1998) Thrombopoietin. N Engl J Med 339:746-754.
22. Kaushansky K (2008) Historical review: Megakaryopoiesis and thrombopoiesis. Blood 111:981-986.
23. Fox N, Priestley G, Papayannopoulou T, Kaushansky K (2002) Thrombopoietin expands hematopoietic stem cells after transplantation. J Clin Invest 110:389-394. (Pubitemid 34847971)
24. Kirito K, Fox N, Kaushansky K (2003) Thrombopoietin stimulates Hoxb4 expression: An explanation for the favorable effects of TPO on hematopoietic stem cells. Blood 102:3172-3178. (Pubitemid 37314753)
25. Yoshihara H, et al. (2007) Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche. Cell Stem Cell 1:685-697. (Pubitemid 350215333)
26. Qian H, et al. (2007) Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells. Cell Stem Cell 1:671-684. (Pubitemid 350215331)
27. Valenzuela DM, et al. (2003) High-throughput engineering of the mouse genome coupled with high-resolution expression analysis. Nat Biotechnol 21:652-659. (Pubitemid 36638092)
28. Ghilardi N, Wiestner A, Skoda RC (1998) Thrombopoietin production is inhibited by a translational mechanism. Blood 92:4023-4030. (Pubitemid 28544314)
29. Wiestner A, Schlemper RJ, van der Maas AP, Skoda RC (1998) An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia. Nat Genet 18:49-52. (Pubitemid 28027878)
30. Manz MG, Miyamoto T, Akashi K, Weissman IL (2002) Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci USA 99:11872-11877. (Pubitemid 34994491)
31. Hao QL, Thiemann FT, Petersen D, Smogorzewska EM, Crooks GM (1996) Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population. Blood 88:3306-3313. (Pubitemid 26365563)
32. Bhatia M, Wang JC, Kapp U, Bonnet D, Dick JE (1997) Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci USA 94:5320-5325. (Pubitemid 27214781)
33. Larochelle A, et al. (1996) Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy. Nat Med 2:1329-1337.
34. Majeti R, Park CY, Weissman IL (2007) Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. Cell Stem Cell 1:635-645. (Pubitemid 350215330)
35. Dick JE, Bhatia M, Gan O, Kapp U, Wang JC (1997) Assay of human stem cells by repopulation of NOD/SCID mice. Stem Cells 15(Suppl 1):199-203; discussion 204-207.
36. Haley PJ (2003) Species differences in the structure and function of the immune system. Toxicology 188:49-71.
37. Mestas J, Hughes CC (2004) Of mice and not men: Differences between mouse and human immunology. J Immunol 172:2731-2738. (Pubitemid 38263654)
38. Rozemuller H, et al. (2004) Enhanced engraftment of human cells in RAG2/gammac double-knockout mice after treatment with CL2MDP liposomes. Exp Hematol 32:1118-1125. (Pubitemid 39469937)
39. Takenaka K, et al. (2007) Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat Immunol 8:1313-1323. (Pubitemid 350138972)
40. Takizawa H, Manz MG (2007) Macrophage tolerance: CD47-SIRP-alpha-mediated signals matter. Nat Immunol 8:1287-1289. (Pubitemid 350131166)
41. Jaiswal S, et al. (2009) CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell 138:271-285.
42. Chao MP, et al. (2010) Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma. Cell 142:699-713.
43. Brehm MA, et al. (2010) Parameters for establishing humanized mouse models to study human immunity: Analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rgamma(null) mutation. Clin Immunol 135:84-98.
44. Poueymirou WT, et al. (2007) F0 generation mice fully derived from gene-targeted embryonic stem cells allowing immediate phenotypic analyses. Nat Biotechnol 25:91-99. (Pubitemid 46091512)